Oceanit CEO, Dr. Patrick Sullivan joined Hawaii Public Radio host, Catherine Cruz to discuss the ASSURE-100 Rapid COVID-19 Test. Their ten minute discussion covered the research & development that went into ASSURE-100, the FDA EUA process, and what comes next.
Currently browsing: Local News
ASSURE In the News
IN THE NEWS | Testing Still Critical As Travel Opens Up in Hawaii
“We know at least 40% to 50% of individuals are asymptomatic positive, so how are those individuals going to know whether they have the disease or not?” Dr. Scott Miscovich of Hawaii’s Premier Medical Group said. “That’s why you still need to have a large amount of surveillance testing available, while you’re pushing your vaccine rates up at the same time.”
IN THE NEWS | Oceanit’s ASSURE-100 in Honolulu Civil Beat
Oceanit recently spoke with journalist, Eleni Avendaño, about the ongoing trials and development of ASSURE rapid tests. Oceanit’s ASSURE is currently in clinical trials in multiple locations as the rapid tests advance towards submission to the U.S. FDA for Emergency Use Authorization (EUA).
Need For and Use of Rapid COVID-19 Testing In Hawaii Grows
COVID-19 tests are likely to remain part of our new normal, even as the overall pandemic situation stabilizes in Hawaii, says Civil Beat’s Eleni Avendaño in a new article published on June 3rd.
IN THE NEWS | Oceanit Progresses Towards FDA EUA Submission
Oceanit has been hard at work to develop and perfect the ASSURE-19 rapid test for submission to the U.S. FDA for emergency use authorization. Hawaii News Now reconnected with Dr. Patrick Sullivan last week to speak about the huge effort being made and the challenges being overcome as ASSURE-19 moves ever-closer to authorization.
IN THE NEWS | The Call for Rapid, Point-of-Teed Testing Gets Louder
In Civil Beat this week, reporter Stewart Yerton explored how the calls for fast, frequent and cheap Covid-19 tests are growing stronger by the day. Experts agree that rapid tests can be the critical piece of the puzzle to solve the spread of Covid-19. By detecting infectiousness rather than just presence of the SARS-CoV-2 virus, we can effectively quarantine those who would readily spread the disease – regardless of if that person exhibits or experiences symptoms or not.
The Aloha Protocol For a Safer Reopening with ASSURE-19
As Oceanit moves ahead with in-vitro and in-vivo testing for the ASSURE-19 rapid point-of-need test kits, Hawaii is seeing high, sustained counts for new covid-19 cases each day. Check out the latest articles and coverage of ASSURE-19 from the Washington Post, Hawaii Public Radio, and Honolulu Star Advertiser.
ASSURE-19 Featured on Hawaii News Now, Honolulu Star Advertiser, and Pacific Business News
Oceanit is focusing on quickly bringing ASSURE-19 to market, organizing manufacturing so that we can provide schools, emergency responders, and airports with a simple saliva test to make high-risk situations safer. This phase of funding and work will help with regulatory compliance and approval, as well as support for accelerating a ‘go to market’ timeline and scale manufacturing.
Press Release | AUG 20: NIH Funding and Moving to Trials
Oceanit Laboratories’ ASSURE-19 rapid point-of-need COVID-19 test has been selected for continued support by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to fill the nation’s critical need for rapid, simple, and affordable COVID-19 testing.
Honolulu Civil Beat – Widespread, Frequent COVID-19 Testing ‘Can Wipe This Off The Planet’
Senior business writer, Stewart Yerton mentioned Oceanit’s ASSURE-19 tests in his Civil Beat article as a possible solution to the expensive, delayed, and low-availability PCR testing in the State of Hawaii. Click to read more.